Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.474, 2005-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Substantial delays in US infant vaccinations: better late than never?
Inpharma, Vol. 1, Iss. 1479, 2005-01 ,pp. :
Access to resources
Recommend
QOL with new triptan no better than with US market leader?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 302, 2001-01 ,pp. :
Moxifloxacin a better option for AECB than levofloxacin?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 300, 2001-01 ,pp. :
Who should receive booster hepatitis B vaccinations?
Inpharma, Vol. 1, Iss. 1225, 2000-01 ,pp. :
Influenza Vaccinations: Who Needs Them and When?
By Hak E. Hoes A.W. Verheij T.J.M.
Drugs, Vol. 62, Iss. 17, 2002-01 ,pp. :